1O9K

Crystal structure of the retinoblastoma tumour suppressor protein bound to E2F peptide

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.6 Å
  • R-Value Free: 0.285 
  • R-Value Work: 0.229 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history. 

Literature

Crystal Structure of the Retinoblastoma Tumor Suppressor Protein Bound to E2F and the Molecular Basis of its Regulation

Xiao, B., Spencer, J., Clements, A., Ali-Khan, N., Mittnacht, S., Broceno, C., Burghammer, M., Perrakis, A., Marmorstein, R., Gamblin, S.J.

(2003) Proc.Natl.Acad.Sci.USA 100: 2363

  • DOI: 10.1073/pnas.0436813100

  • PubMed Abstract: 

    • The retinoblastoma tumor suppressor protein (pRb) regulates the cell cycle, facilitates differentiation, and restrains apoptosis. Furthermore, dysfunctional pRb is thought to be involved in the development of most human malignancies. Many of the func ...

    The retinoblastoma tumor suppressor protein (pRb) regulates the cell cycle, facilitates differentiation, and restrains apoptosis. Furthermore, dysfunctional pRb is thought to be involved in the development of most human malignancies. Many of the functions of pRb are mediated by its regulation of the E2F transcription factors. To understand the structural basis for this regulation, we have determined the crystal structure of a fragment of E2F in complex with the pocket domain of the tumor suppressor protein. The pRb pocket, comprising the A and B cyclin-like domains, is the major focus of tumourigenic mutations in the protein. The fragment of E2F used in our structural studies, residues 409-426 of E2F-1, represents the core of the pRb-binding region of the transcription factor. The structure shows that E2F binds at the interface of the A and B domains of the pocket making extensive interactions with conserved residues from both. We show by solution studies that a second site, probably contained within the "marked box" region of E2F, is responsible for additional interactions with the pRb pocket but is insufficient for complex formation on its own. In addition, we show that the interaction of the core binding fragment of E2F with pRb is inhibited by phosphorylation of the tumor suppressor protein by CDK2cyclin DE. Finally, our data reveal that the tight binding of the human papillomavirus E7 oncoprotein to pRb prevents subsequent interactions with the marked box region of E2F but not with its core binding region.

    Organizational Affiliation: 

    Division of Protein Structure, National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
RETINOBLASTOMA-ASSOCIATED PROTEIN
A, C, E, G
218Homo sapiensMutation(s): 0 
Gene Names: RB1
Find proteins for P06400 (Homo sapiens)
Go to Gene View: RB1
Go to UniProtKB:  P06400
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
RETINOBLASTOMA-ASSOCIATED PROTEIN
B, D, F, H
152Homo sapiensMutation(s): 0 
Gene Names: RB1
Find proteins for P06400 (Homo sapiens)
Go to Gene View: RB1
Go to UniProtKB:  P06400
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
TRANSCRIPTION FACTOR E2F1
P, Q, R, S
18Homo sapiensMutation(s): 0 
Gene Names: E2F1 (RBBP3)
Find proteins for Q01094 (Homo sapiens)
Go to Gene View: E2F1
Go to UniProtKB:  Q01094
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.6 Å
  • R-Value Free: 0.285 
  • R-Value Work: 0.229 
  • Space Group: C 1 2 1
Unit Cell:
Length (Å)Angle (°)
a = 101.996α = 90.00
b = 158.548β = 93.70
c = 110.617γ = 90.00
Software Package:
Software NamePurpose
DENZOdata reduction
AMoREphasing
REFMACrefinement
SCALEPACKdata scaling

Structure Validation

View Full Validation Report or Ramachandran Plots


View more in-depth experimental data

Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2003-03-06
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Advisory, Version format compliance